Effects of Actissist, a digital health intervention for early psychosis: A randomized clinical trial

Cornwall Partnership NHS Foundation Trust, Devon Partnership NHS Trust and Livewell Southwest will be the first NHS trusts in the country to trial CareLoop Health’s digital platform to prevent psychosis relapse across a region. 

Working in partnership with Health Innovation South West (HIN SW), CareLoop Health has been awarded £488k by Small Business Research Initiative (SBRI) Healthcare to give patients in Southwest England access to its platform over the course of a year. 

Around 1 in 100 people live with psychosis in the UK. For 80% of these people, the risk of relapse each year is one in four.  Relapses are harder to treat than a first episode of psychosis, debilitating and life interrupting, and often leading to hospital stays. 

Back to all posts